公司概述
ZenaTech, Inc. operates as an enterprise software technology company based in Canada, specializing in the development of cloud-based software applications tailored for specific industrial sectors. The company focuses its product offerings on the medical records industry, providing essential cloud-based solutions for managing electronic health data, alongside software designed for automated facility management and center operations as well as safety and compliance protocols. Operating within the Technology sector and specifically the Software - Infrastructure industry, ZenaTech functions as a provider of digital infrastructure that supports critical business processes in healthcare and facility management. With a market capitalization of $122.76M, annual revenue of $8.40M, and a workforce of 30 employees, the company represents a small-cap entity with significant revenue expansion relative to its headcount. These valuation and revenue metrics indicate that the market is pricing the company based on high-growth expectations rather than current profitability, suggesting a position where investor sentiment is heavily weighted toward future potential rather than established earnings power.
财务健康
The company reported a total revenue of $8.40M over the trailing twelve months, yet recorded a net income of $-26,419,976, revealing a substantial gap between top-line sales and bottom-line results. This disparity indicates a highly volatile cost structure where expenses, likely driven by R&D or operational scaling costs, significantly exceed the gross revenue generated. The company generated an EBITDA of $-13,601,560 and a Free Cash Flow of $-23,226,480, which demonstrates a complete lack of financial flexibility to fund operations internally without external capital injections. Margin analysis shows a Gross Margin of 100.0%, implying that the cost of goods sold is negligible or zero for this software model, while an Operating Margin of -110.5% and a Profit Margin of 0.0% highlight severe operational inefficiencies or high period-specific costs relative to sales. On the balance sheet, ZenaTech holds $19.53M in cash against $32.11M in debt, resulting in a Debt to Equity ratio of 77.92, which characterizes a highly leveraged financial structure rather than a conservative one. Despite the leverage, the Current Ratio stands at 5.42, indicating that the company possesses more than five times the current assets needed to cover its short-term liabilities, suggesting adequate short-term liquidity coverage despite the negative cash flow generation. Return on Equity is -100.9% and Return on Assets is -17.6%, metrics that reveal that management has not yet generated positive returns on the capital invested or assets held, reflecting a period of heavy investment or structural losses.
估值评估
ZenaTech trades with a Trailing P/E ratio of 54.50 and a Forward P/E of -13.12, a divergence that implies the market expects earnings to turn positive in the future, although the negative forward multiple reflects the current expectation of continued losses. The Price to Book ratio is -10.86, indicating that the market prices the company at a significant premium over its book value, or conversely, that the book value is negative due to accumulated losses, rendering the traditional P/B metric less meaningful for valuation. The Price to Sales ratio stands at 14.62, while the EV/EBITDA is -10.83, suggesting that investors are valuing the company primarily on its revenue multiple rather than earnings multiples, which is common for pre-profitability software firms. The stock has a 52-week high of $7.11 and a 52-week low of $1.92; without a specific current price provided in the facts, the trading range defines the volatility band within which the asset has moved over the past year. The Beta is listed as N/A, meaning that standard volatility relative to the broader market cannot be quantified with the available data, preventing a direct comparison of price sensitivity to market movements.
Growth & Income
Revenue growth year-over-year is reported at an extraordinary 1225.3%, while Earnings Growth is N/A due to the company's negative net income, implying that revenue expansion is occurring without corresponding immediate profitability. Since the company does not pay dividends, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, it follows a capital allocation strategy where earnings are not distributed but are instead reinvested into growth initiatives to achieve profitability. The combination of massive revenue growth and a complete absence of dividends indicates that the firm is in an aggressive expansion phase, prioritizing market share acquisition and product development over returning cash to shareholders. Overall, the growth and income profile is characterized by rapid top-line expansion funded by cash reserves and external financing, with no current income generation to support shareholder returns.